| Sources | Names Used |
|---|---|
| CTRPv2 | BRD-K02251932 |
| PharmacoGx | BRD-K02251932 |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SH2D1A | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | MYO18B | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | PDE7A | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |
| mRNA | MSH6 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | OXR1 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | KMT2C | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | BLM | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0001 |
| mRNA | CDCA7 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | ZNF282 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | TCF3 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
